{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:27:28Z","timestamp":1761863248361,"version":"3.40.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.intimp.2013.08.009","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T05:30:27Z","timestamp":1379050227000},"page":"744-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["1,25-dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K\/Akt\/mTOR signaling cascade"],"prefix":"10.1016","volume":"17","author":[{"given":"Ananya","family":"Datta-Mitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siba P.","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Kundu-Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.08.009_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.intimp.2013.08.009_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpendmet0716","article-title":"Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity","volume":"4","author":"Adams","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.intimp.2013.08.009_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2013.08.009_bb0025","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-2133.2010.09692.x","article-title":"1,24-Dihydroxyvitamin D(3) (tacalcitol) prevents skin T-cell infiltration","volume":"162","author":"Yamanaka","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jbspin.2010.09.018","article-title":"Vitamin D and inflammation","volume":"77","author":"Guillot","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2013.08.009_bb0035","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1186\/ar4060","article-title":"Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation","volume":"14","author":"Terrier","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.intimp.2013.08.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-013-8361-3","article-title":"The implication of vitamin D and autoimmunity: a comprehensive review","author":"Yang","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcb.20095","article-title":"Vitamin D, regulated keratinocyte differentiation","volume":"92","author":"Bikle","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.intimp.2013.08.009_bb0050","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10552-004-1661-4","article-title":"The epidemiology of vitamin D and cancer incidence and mortality: a review (United States)","volume":"16","author":"Giovannucci","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.intimp.2013.08.009_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1158\/1535-7163.MCT-05-0539","article-title":"Promise of vitamin D analogues in the treatment of hyperproliferative conditions","volume":"5","author":"Masuda","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2013.08.009_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00280-009-1000-2","article-title":"A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors","volume":"65","author":"Muindi","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/1078-0432.CCR-06-1165","article-title":"A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors","volume":"13","author":"Fakih","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2013.08.009_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-3083.2005.01343.x","article-title":"Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis","volume":"20","author":"Kragballe","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","article-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","volume":"82","author":"Douglas","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0085","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.bmcl.2011.02.025","article-title":"1alpha,25-Dihydroxyvitamin D3-3beta-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action","volume":"21","author":"Ray","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.intimp.2013.08.009_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/abbi.1999.1353","article-title":"Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3)","volume":"370","author":"Chen","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.intimp.2013.08.009_bb0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jcb.10585","article-title":"1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells","volume":"89","author":"Swamy","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.intimp.2013.08.009_bb0100","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1158\/1078-0432.CCR-04-0881","article-title":"Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells","volume":"10","author":"Swamy","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2013.08.009_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbrc.2007.07.012","article-title":"Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells","volume":"361","author":"Lambert","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2013.08.009_bb0110","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1158\/1940-6207.CAPR-10-0122","article-title":"A vitamin D receptor-alkylating derivative of 1alpha,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth","volume":"3","author":"Lambert","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.intimp.2013.08.009_bb0115","first-page":"1875","article-title":"Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells","volume":"30","author":"Persons","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.intimp.2013.08.009_bb0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1747-0285.2007.00567.x","article-title":"Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma","volume":"70","author":"Lange","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.intimp.2013.08.009_bb0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.intimp.2013.08.009_bb0130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.10580","article-title":"The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells","volume":"89","author":"Mahon","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.intimp.2013.08.009_bb0135","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","article-title":"Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation","volume":"57","author":"Bhalla","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.intimp.2013.08.009_bb0140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-Dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.08.009_bb0145","doi-asserted-by":"crossref","first-page":"1704S","DOI":"10.1093\/jn\/125.suppl_6.1704S","article-title":"Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions","volume":"125","author":"Lemire","year":"1995","journal-title":"J Nutr"},{"key":"10.1016\/j.intimp.2013.08.009_bb0150","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.0801543","article-title":"Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response","volume":"182","author":"Tang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0155","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2220\/biomedres.27.1","article-title":"Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity","volume":"27","author":"Imazeki","year":"2006","journal-title":"Biomed Res"},{"key":"10.1016\/j.intimp.2013.08.009_bb0165","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/eji.201242370","article-title":"The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells","volume":"42","author":"Urry","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0170","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/eji.200324532","article-title":"The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing","volume":"34","author":"Topilski","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ni1433","article-title":"DCs metabolize sunlight-induced vitamin D3 to \u2018program\u2019 T cell attraction to the epidermal chemokine CCL27","volume":"8","author":"Sigmundsdottir","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0180","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2008-0078","article-title":"Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells","volume":"149","author":"Borgogni","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2013.08.009_bb0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000058001","article-title":"Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3","volume":"128","author":"Rausch-Fan","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0190","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2013.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2013.08.009_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-012-8309-z","article-title":"A Cutting Edge Overview: Psoriatic Disease","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2013.08.009_bb0215","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2013.08.009_bb0220","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2013.08.009_bb0225","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.clindermatol.2007.08.011","article-title":"The cytokine and chemokine network in psoriasis","volume":"25","author":"Nickoloff","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ecn.2011.0294","article-title":"Cytokine network in psoriasis revisited","volume":"22","author":"Michalak-Stoma","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.intimp.2013.08.009_bb0235","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/art.23045","article-title":"The role of T lymphocytes in rheumatoid arthritis and other autoimmune diseases","volume":"58","author":"Bennett","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2013.08.009_bb0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2013.08.009_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2013.08.009_bb0250","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/jid.2013.3","article-title":"1-alpha,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT\/mTOR Signaling Cascades: A Previously Unreported Therapeutic Agent for Psoriasis","volume":"133","author":"Datta Mitra","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0255","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2353\/ajpath.2008.070710","article-title":"Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis","volume":"172","author":"Raychaudhuri","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0260","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1582-4934.2011.01369.x","article-title":"Profilin1 facilitates staurosporine-triggered apoptosis by stabilizing the integrin beta1-actin complex in breast cancer cells","volume":"16","author":"Yao","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.intimp.2013.08.009_bb0265","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/1933719111399929","article-title":"CDB-4124 does not cause apoptosis in cultured fibroid cells","volume":"18","author":"Roeder","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.intimp.2013.08.009_bb0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.intimp.2013.08.009_bb0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11926-012-0244-8","article-title":"Vitamin D deficiency: subclinical and clinical consequences on musculoskeletal health","volume":"14","author":"Haroon","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.intimp.2013.08.009_bb0280","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1073\/pnas.78.8.4990","article-title":"Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3","volume":"78","author":"Abe","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.08.009_bb0285","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.intimp.2013.08.009_bb0290","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI111557","article-title":"Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)","volume":"74","author":"Rigby","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.08.009_bb0295","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.4049\/jimmunol.179.9.6273","article-title":"Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes","volume":"179","author":"Gorman","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0300","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10067-012-2080-7","article-title":"Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis","volume":"31","author":"Song","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.intimp.2013.08.009_bb0305","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10067-012-2154-6","article-title":"Severe deficiency of 25-hydroxyvitamin D(3) (25-OH-D (3)) is associated with high disease activity of rheumatoid arthritis","volume":"32","author":"Haga","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0923-1811(90)90120-3","article-title":"Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level","volume":"1","author":"Morimoto","year":"1990","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2013.08.009_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0961203309345775","article-title":"Vitamin D insufficiency in a large female SLE cohort","volume":"19","author":"Toloza","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2013.08.009_bb0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-008-0676-1","article-title":"Vitamin D deficiency in patients with active systemic lupus erythematosus","volume":"20","author":"Borba","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.intimp.2013.08.009_bb0325","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31825fdec7","article-title":"Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis","volume":"79","author":"Runia","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2013.08.009_bb0330","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-2952(00)00564-5","article-title":"Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis","volume":"61","author":"Stio","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0335","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/08916939309077355","article-title":"Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+and CD45R0+ cells","volume":"14","author":"Muller","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2013.08.009_bb0340","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.4049\/jimmunol.134.5.3032","article-title":"1,25-Dihydroxyvitamin D3 suppresses human T helper\/inducer lymphocyte activity in vitro","volume":"134","author":"Lemire","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0345","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.1780380812","article-title":"A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis","volume":"38","author":"van der Lubbe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2013.08.009_bb0350","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0889-857X(05)70026-0","article-title":"Monoclonal antibodies to CD4","volume":"24","author":"Breedveld","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.intimp.2013.08.009_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780340202","article-title":"Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody","volume":"34","author":"Horneff","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2013.08.009_bb0360","first-page":"1845","article-title":"Persistent depletion of CD4+ T cells and inversion of the CD4\/CD8 T cell ratio induced by anti-CD4 therapy","volume":"19","author":"Horneff","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2010.03.037","article-title":"Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system","volume":"121","author":"Baeke","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ard.58.2.118","article-title":"Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes","volume":"58","author":"Tetlow","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2013.08.009_bb0375","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/jpet.109.159517","article-title":"Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis","volume":"332","author":"Jin","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2013.08.009_bb0380","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clim.2006.07.007","article-title":"Rheumatoid synovial fluid T cells are sensitive to APO2L\/TRAIL","volume":"122","author":"Martinez-Lorenzo","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0385","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2013.08.009_bb0390","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2009.07657.x","article-title":"Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2013.08.009_bb0395","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14728220903136775","article-title":"Targeting the PI3K\/AKT\/mTOR signaling network in acute myelogenous leukemia","volume":"18","author":"Martelli","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.intimp.2013.08.009_bb0400","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/excr.1999.4690","article-title":"The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB","volume":"253","author":"Kandel","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.intimp.2013.08.009_bb0405","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.30278","article-title":"Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent","volume":"63","author":"Saxena","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2013.08.009_bb0410","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","article-title":"IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade","volume":"60","author":"Mitra","year":"2012","journal-title":"Cytokine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:39:19Z","timestamp":1746023959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1567576913003305"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.08.009","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,25-dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K\/Akt\/mTOR signaling cascade","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}